review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.ATV.13.5.629 |
P698 | PubMed publication ID | 8485114 |
P50 | author | Katherine Cianflone | Q66764527 |
Allan D Sniderman | Q91894181 | ||
P433 | issue | 5 | |
P304 | page(s) | 629-636 | |
P577 | publication date | 1993-05-01 | |
P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
P1476 | title | Substrate delivery as a determinant of hepatic apoB secretion | |
P478 | volume | 13 |
Q28346400 | A role for smooth endoplasmic reticulum membrane cholesterol ester in determining the intracellular location and regulation of sterol-regulatory-element-binding protein-2 |
Q33746676 | Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion |
Q35849439 | Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function |
Q36509548 | Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations |
Q33858526 | Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion. |
Q41874838 | Are we waking up to the effects of NEFA? |
Q74012709 | Characterization and modulation of LP(a) in human hepatoma HEPG2 cells |
Q42982452 | Characterization of the inhibitory effects of bile acids on very-low-density lipoprotein secretion by rat hepatocytes in primary culture |
Q42518323 | Cholesterol esters regulate apoB48 secretion in CaCo2 cells |
Q51567163 | Cholesterol synthesis is increased in mixed hyperlipidaemia. |
Q37737551 | Diagnosis and treatment of apolipoprotein B dyslipoproteinemias. |
Q73228450 | Different patterns of brisk walking are equally effective in decreasing postprandial lipaemia |
Q34564452 | Differential effect of corn oil-based low trans structured fat on the plasma and hepatic lipid profile in an atherogenic mouse model: comparison to hydrogenated trans fat. |
Q73934655 | Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man |
Q71965309 | Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects |
Q47987252 | Divergent responses of the liver to increased delivery of glucose or fatty acids: implications for the pathogenesis of type IV hyperlipoproteinemia |
Q37136074 | Dyslipidaemia in Adult Growth Hormone (GH) Deficiency and the Effect of GH Replacement Therapy: A Review |
Q33756050 | Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice |
Q30428195 | Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure |
Q54147254 | Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation. |
Q48787738 | Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia. |
Q33908606 | Exercise and dietary-mediated reductions in postprandial lipemia. |
Q34223452 | Extended-release niacin acutely suppresses postprandial triglyceridemia |
Q40802354 | Familial lipoprotein disorders and premature coronary artery disease. |
Q44279291 | Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men. |
Q35395461 | Fetal macrosomia related to maternal poorly controlled type 1 diabetes strongly impairs serum lipoprotein concentrations and composition |
Q77452737 | Genetics of lipoprotein disorders |
Q35919242 | Hepatic regulation of apolipoprotein B. |
Q37354550 | Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet |
Q54075056 | Impaired postprandial tissue regulation of blood flow in insulin resistance: a determinant of cardiovascular risk? |
Q35137720 | Inflammation in sleep apnea: an update. |
Q42166736 | Influence of simvastatin on apoB-100 secretion in non-obese subjects with mild hypercholesterolemia. |
Q77135898 | Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol |
Q35212552 | Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia |
Q35754362 | Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies |
Q36093354 | Metabolic dysfunction in obstructive sleep apnea: A critical examination of underlying mechanisms |
Q27863447 | Microsomal triglyceride transfer protein |
Q34504405 | NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, decreases apolipoprotein B-100 secretion from Hep G2 cells |
Q34074263 | Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) stimulates VLDL assembly through activation of cell death-inducing DFFA-like effector B (CideB) |
Q73701461 | Phenotype expression in familial combined hyperlipidemia |
Q42981221 | Phosphatidylcholine increases the secretion of triacylglycerol-rich lipoproteins by CaCo-2 cells |
Q34499464 | Polymorphism of rs1044925 in the acyl-CoA:cholesterol acyltransferase-1 gene and serum lipid levels in the Guangxi Bai Ku Yao and Han populations |
Q93178699 | Population-Level Analysis to Determine Parameters That Drive Variation in the Plasma Metabolite Profiles |
Q33746649 | Regulation of Plasma fatty acid metabolism |
Q42274164 | Regulation of plasma LDL: the apoB paradigm |
Q41004209 | Role of insulin in hepatic fatty acid partitioning: emerging concepts |
Q33591459 | Role of the enterohepatic circulation of bile salts in lipoprotein metabolism |
Q34121180 | Shifting the LDL-receptor paradigm in familial hypercholesterolemia: novel insights from recent kinetic studies of apolipoprotein B-100 metabolism |
Q73409184 | Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes |
Q71814893 | Simvastatin decreases the hepatic secretion of very‐low‐density lipoprotein apolipoprotein B‐100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications |
Q28185968 | Structure of the human acyl-CoA:cholesterol acyltransferase-2 (ACAT-2) gene and its relation to dyslipidemia |
Q41519599 | The acylation stimulating protein pathway: Clinical implications |
Q24794764 | The effect of Puerariae radix on lipoprotein metabolism in liver and intestinal cells |
Q77794967 | The influence of exercise on postprandial triacylglycerol metabolism |
Q57420304 | The reduction in postprandial lipemia after exercise is independent of the relative contributions of fat and carbohydrate to energy metabolism during exercise |
Q42538179 | Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Tr |
Q73625943 | Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells |
Search more.